Valuation : Baxter International Inc.

Market Cap 13.35B 11.49B 10.81B 9.88B 18.48B 1,261B 18.53B 128B 49.58B 647B 50.15B 49.05B 2,084B P/E 2026 *
33.1x
P/E 2027 * 21.6x
Enterprise Value 20.25B 17.43B 16.4B 14.98B 28.02B 1,912B 28.09B 194B 75.18B 981B 76.04B 74.39B 3,160B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.66x
Free-Float
75.38%
Yield 2026 *
0.15%
Yield 2027 * 0.16%
1 day+1.02%
1 week-1.15%
Current month-0.65%
1 month-5.49%
3 months+33.28%
6 months+38.87%
Current year+35.16%
1 week 25.17
Extreme 25.17
26.56
1 month 25.17
Extreme 25.17
28.02
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Director of Finance/CFO 52 2026-03-15
Chief Tech/Sci/R&D Officer 57 2023-12-31
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Tax

President, Front Line Care

-2,098 0.0004%
9/2/26 Tax

Chief Executive Officer

-54,276 0.0105%
9/1/26 Tax

President, CCS

-750 0.0001% -
Change 5-day change 1-year change 3-year change Capi.($)
+1.02%-1.15%+5.77%-33.75% 13.35B
-0.42%-3.68%-18.51%+7.39% 187B
+1.15%+3.22%+1.37%+17.42% 120B
-1.86%+2.77%+13.15%+91.44% 63.15B
-1.31%-1.09%+17.67%+43.65% 51.75B
-1.54%-2.52%-3.98%-32.30% 50.32B
-2.02%-3.22%+9.18%-12.39% 33.17B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+35.59%-15.78% 23.93B
-1.44%-4.21%-8.07%+11.30% 22.99B
Average -0.72%-0.18%+5.80%+8.55% 59.87B
Weighted average by Cap. -0.52%-0.00%-1.26%+15.73%

Financials

2026 *2027 *
Net sales 11.62B 10B 9.41B 8.59B 16.07B 1,097B 16.12B 111B 43.13B 563B 43.62B 42.67B 1,813B 11.86B 10.21B 9.6B 8.77B 16.41B 1,120B 16.46B 113B 44.04B 575B 44.55B 43.58B 1,851B
Net income 372M 320M 301M 275M 515M 35.12B 516M 3.56B 1.38B 18.02B 1.4B 1.37B 58.05B 687M 592M 557M 508M 951M 64.91B 954M 6.58B 2.55B 33.3B 2.58B 2.53B 107B
Net Debt 6.9B 5.93B 5.58B 5.1B 9.54B 651B 9.57B 65.98B 25.6B 334B 25.9B 25.33B 1,076B 6.32B 5.44B 5.11B 4.67B 8.74B 596B 8.76B 60.43B 23.45B 306B 23.72B 23.2B 986B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-09-04 US$25.83 +1.02% 3,415,196
26-09-03 US$25.57 -0.51% 4,699,471
26-09-02 US$25.70 +0.86% 4,167,853
26-09-01 US$25.48 -2.00% 5,275,633
26-08-31 US$26.00 -0.50% 3,992,222
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
25.83USD
Average target price
28.73USD
Spread / Average Target
+11.22%

Quarterly revenue - Rate of surprise